TCR2 Therapeutics所有资讯

TCR2 Therapeutics | 4：持股变动声明-股东 TANG KEVIN C

02/15 06:29

TCR2 Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-TANG CAPITAL PARTNERS, LP(0%),TANG CAPITAL MANAGEMENT, LLC(0%)等

02/15 05:03

TCR2 Therapeutics | 4：持股变动声明-股东 UBS Oncology Impact Fund L.P.

2023/06/06 04:37

TCR2 Therapeutics | 4：持股变动声明-股东 MPM SunStates Fund, L.P.

2023/06/06 04:36

TCR2 Therapeutics | 4：持股变动声明-股东 MPM BioVentures 2014, L.P.

2023/06/06 04:36

TCR2 Therapeutics | 4：持股变动声明-董事 GADICKE ANSBERT

2023/06/06 04:35

TCR2 Therapeutics | 4：持股变动声明-董事 Allen Andrew R

2023/06/02 04:33

TCR2 Therapeutics | 4：持股变动声明-董事 Tomasello Shawn

2023/06/02 04:32

TCR2 Therapeutics | 4：持股变动声明-首席财务官 Sullivan Eric

2023/06/02 04:31

TCR2 Therapeutics | 4：持股变动声明-高管 Cardama Alfonso Quintas

2023/06/02 04:29

TCR2 Therapeutics | 4：持股变动声明-首席运营官 Olagunju Peter

2023/06/02 04:27

TCR2 Therapeutics | 4：持股变动声明-董事 Webster Stephen W

2023/06/02 04:25

TCR2 Therapeutics | 4：持股变动声明-高管 Harrison Rosemary

2023/06/02 04:23

TCR2 Therapeutics | 4：持股变动声明-高管 Menzel Garry E

2023/06/02 04:22

TCR2 Therapeutics | 4：持股变动声明-首席人事官 Justice Angela

2023/06/02 04:21

TCR2 Therapeutics | 4：持股变动声明-董事 Hoos Axel

2023/06/02 04:20

TCR2 Therapeutics | 4：持股变动声明-董事 Hegde Priti

2023/06/02 04:18

TCR2 Therapeutics | 4：持股变动声明-董事 Gibson Neil W

2023/06/02 04:15

TCR2 Therapeutics | 4：持股变动声明-股东 TANG KEVIN C

2023/05/31 08:02

TCR2 Therapeutics | 4：持股变动声明-股东 MPM ASSET MANAGEMENT LLC

2023/05/25 04:39